The Child Hatchery, 1896

The incubator exhibitions of the late 19th and early 20th centuries publicized the care of premature babies.

Written byCatherine Offord
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

BEGINNINGS: Alexandre Lion’s 1889 design for a premature-baby incubator included a thermostat-regulated heater and forced ventilation system. Physician-cum-showman Martin Couney (right) helped publicize the incubator technologies designed by Lion and others for premature infant care. However, some of his shows in amusement parks at Coney Island and elsewhere caused him to be associated by many with exploitative “freak shows”—an image he spent most of his life trying to shake. L. FISCHER, INFANT-FEEDING IN ITS RELATION TO HEALTH AND DISEASE, F. A. DAVIS COMPANY, 1901; New York World’s Fair, 1939-1940, New York, N.Y.

In the 1880s, premature birth was mostly a mother’s issue. Some hospitals used simple technology, inspired by chicken incubators and heated by hot water bottles, to keep premature babies warm. And studies conducted by the makeshift incubators’ creator, Stéphane Tarnier, showed that such care reduced infant mortality. Still, most hospitals focused “just as much on breastfeeding and maternal care to save the baby,” says Jeffrey Baker, a medical historian at Duke University.

French physician Alexandre Lion took a different approach. In 1889, he patented an incubator in which temperature was regulated by a thermostat—“a tricky technology” back then, says Baker—and ventilation was provided by an electric fan. Rather than extra support, Lion’s incubator was “almost an artificial mother.”

But such newfangled technology wasn’t cheap. And ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • After undergraduate research with spiders at the University of Oxford and graduate research with ants at Princeton University, Catherine left arthropods and academia to become a science journalist. She has worked in various guises at The Scientist since 2016. As Senior Editor, she wrote articles for the online and print publications, and edited the magazine’s Notebook, Careers, and Bio Business sections. She reports on subjects ranging from cellular and molecular biology to research misconduct and science policy. Find more of her work at her website.

    View Full Profile

Published In

March 2018

The Transgender Brain

Researchers seek clues to the origins of gender dysphoria

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies